Novadip Biosciences

Novadip Biosciences

HealthRegenerative MedicineB2B📍 Belgium

Novadip Biosciences is a Belgian late-stage clinical biotech company specializing in regenerative medicine. They have developed a proprietary platform using adipose-derived stem cells to create tissue for healing bone defects and fractures. This funding will support their pivotal Phase 3 clinical trial for NVD003 and preparation for regulatory submission in the United States.

Visit website ↗
Total raised
Undisclosed
tracked to date
Latest round
Convertible
Sep 21, 2026
Known investors
8
led by New Science Ventures

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Belgium.

Claim this profile →

Funding history

  1. 1
    €10.4 millionConvertibleSep 21, 2026

    Led by New Science Ventures

    Announcement ↗

Founder

Dr. Denis Dufrane
Dr. Denis Dufrane
founder and CEO

Investors in Novadip Biosciences

Backers from this company's tracked funding rounds.

  • NNew Science VenturesLead investorVC firm
  • FFund+VC firm
  • WWallonie EntreprendreVC firm
  • VVIVES FundVC firm
  • OORSA TechVC firm
  • SSambrinvestVC firm
  • NNoshaqVC firm
  • IInvest.BWVC firm

Novadip Biosciences in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile